Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Morel

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Journal of Hepatology|December 1, 2025
Targeting ATR to overcome cisplatin resistance in hepatoblastomaPierre Morel-Ribeiro, Marianna Cornet, Jill Pilet, et al.
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Leukemia|November 26, 2022
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's MacroglobulinemiaIrene Dogliotti, Cristina Jiménez, Marzia Varettoni, et al.
American Journal of Hematology|December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patientsSylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
Blood Advances|January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS StudyCaroline Houillier, Sylvain Dureau, Luc Taillandier, et al.
Leukemia|October 7, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphomaDavid Vallois, Edoardo Missiaglia, Luis Veloza, et al.
Nature Medicine|April 11, 2017
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stabilityAnne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, et al.
Haematologica|June 16, 2022
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcomeLuis Veloza, Doriane Cavalieri, Edoardo Missiaglia, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|December 1, 2025
Targeting ATR to overcome cisplatin resistance in hepatoblastomaPierre Morel-Ribeiro, Marianna Cornet, Jill Pilet, et al.
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Leukemia|November 26, 2022
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's MacroglobulinemiaIrene Dogliotti, Cristina Jiménez, Marzia Varettoni, et al.
American Journal of Hematology|December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patientsSylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
Blood Advances|January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS StudyCaroline Houillier, Sylvain Dureau, Luc Taillandier, et al.
Leukemia|October 7, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphomaDavid Vallois, Edoardo Missiaglia, Luis Veloza, et al.
Nature Medicine|April 11, 2017
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stabilityAnne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, et al.
Haematologica|June 16, 2022
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcomeLuis Veloza, Doriane Cavalieri, Edoardo Missiaglia, et al.
Pageof 16